Literature DB >> 29348164

IFCC Working Group Recommendations for Assessing Commutability Part 3: Using the Calibration Effectiveness of a Reference Material.

Jeffrey R Budd1, Cas Weykamp2, Robert Rej3, Finlay MacKenzie4, Ferruccio Ceriotti5, Neil Greenberg6, Johanna E Camara7, Heinz Schimmel8, Hubert W Vesper9, Thomas Keller10, Vincent Delatour11, Mauro Panteghini12, Chris Burns13, W Greg Miller14.   

Abstract

A process is described to assess the commutability of a reference material (RM) intended for use as a calibrator based on its ability to fulfill its intended use in a calibration traceability scheme to produce equivalent clinical sample (CS) results among different measurement procedures (MPs) for the same measurand. Three sources of systematic error are elucidated in the context of creating the calibration model for translating MP signals to measurand amounts: calibration fit, calibrator level trueness, and commutability. An example set of 40 CS results from 7 MPs is used to illustrate estimation of bias and variability for each MP. The candidate RM is then used to recalibrate each MP, and its effectiveness in reducing the systematic error among the MPs within an acceptable level of equivalence based on medical requirements confirms its commutability for those MPs. The RM is declared noncommutable for MPs for which, after recalibration, the CS results do not agree with those from other MPs. When a lack of agreement is found, other potential causes, including lack of calibration fit, should be investigated before concluding the RM is noncommutable. The RM is considered fit for purpose for those MPs where commutability is demonstrated.
© 2017 American Association for Clinical Chemistry.

Entities:  

Mesh:

Year:  2018        PMID: 29348164     DOI: 10.1373/clinchem.2017.277558

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

Review 1.  Harmonization of Liquid Chromatography-Tandem Mass Spectrometry Protein Assays.

Authors:  Alan L Rockwood; Mark S Lowenthal; Cory Bystrom
Journal:  Clin Lab Med       Date:  2018-09       Impact factor: 1.935

2.  How to Really Understand and Improve the System of Internal Quality Control and External Quality Assessment in the Accreditation Process of the Medical Laboratory?

Authors:  Milan Skitek; Flávia Martinello; Aleš Jerin
Journal:  EJIFCC       Date:  2022-04-11

3.  IFCC Working Group Recommendations for Correction of Bias Caused by Noncommutability of a Certified Reference Material Used in the Calibration Hierarchy of an End-User Measurement Procedure.

Authors:  W Greg Miller; Jeffrey Budd; Neil Greenberg; Cas Weykamp; Harald Althaus; Heinz Schimmel; Mauro Panteghini; Vincent Delatour; Ferruccio Ceriotti; Thomas Keller; Douglas Hawkins; Chris Burns; Robert Rej; Johanna E Camara; Finlay MacKenzie; Eline van der Hagen; Hubert Vesper
Journal:  Clin Chem       Date:  2020-06-01       Impact factor: 8.327

4.  IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design.

Authors:  W Greg Miller; Heinz Schimmel; Robert Rej; Neil Greenberg; Ferruccio Ceriotti; Chris Burns; Jeffrey R Budd; Cas Weykamp; Vincent Delatour; Göran Nilsson; Finlay MacKenzie; Mauro Panteghini; Thomas Keller; Johanna E Camara; Ingrid Zegers; Hubert W Vesper
Journal:  Clin Chem       Date:  2018-01-18       Impact factor: 8.327

5.  Commutability Assessment of Candidate External Quality Assessment Materials for Aminotransferase Activity Measurements Based on Different Approaches in China.

Authors:  Qichen Long; Tianqi Qi; Tianjiao Zhang; Jing Wang; Jie Zeng; Ying Yan; Meng Wang; Wei Huang; Haijian Zhao; Wenxiang Chen; Chuanbao Zhang
Journal:  Ann Lab Med       Date:  2020-08-25       Impact factor: 3.464

6.  Paving the way for establishing a reference measurement system for standardization of plasma prothrombin time: Harmonizing the manual tilt tube method.

Authors:  Antonius M H P van den Besselaar; Claudia J J van Rijn; Charmane F Abdoel; Veena Chantarangkul; Erica Scalambrino; Steve Kitchen; Armando Tripodi; Anita M Woolley; Lidia Padovan; Christa M Cobbaert
Journal:  J Thromb Haemost       Date:  2020-06-25       Impact factor: 5.824

7.  Commutability Assessment of Processed Human Plasma Samples for Normetanephrine and Metanephrine Measurements Based on the Candidate Reference Measurement Procedure.

Authors:  Yuhang Deng; Qingxiang Liu; Zhenni Liu; Haijian Zhao; Weiyan Zhou; Chuanbao Zhang
Journal:  Ann Lab Med       Date:  2022-09-01       Impact factor: 4.941

8.  An updated protocol based on CLSI document C37 for preparation of off-the-clot serum from individual units for use alone or to prepare commutable pooled serum reference materials.

Authors:  Uliana Danilenko; Hubert W Vesper; Gary L Myers; Patric A Clapshaw; Johanna E Camara; W Greg Miller
Journal:  Clin Chem Lab Med       Date:  2020-02-25       Impact factor: 8.490

9.  Assessment of serum total 25-hydroxyvitamin D assay commutability of Standard Reference Materials and College of American Pathologists Accuracy-Based Vitamin D (ABVD) Scheme and Vitamin D External Quality Assessment Scheme (DEQAS) materials: Vitamin D Standardization Program (VDSP) Commutability Study 2.

Authors:  Johanna E Camara; Stephen A Wise; Andrew N Hoofnagle; Emma L Williams; Graham D Carter; Julia Jones; Carolyn Q Burdette; Grace Hahm; Federica Nalin; Adam J Kuszak; Joyce Merkel; Ramón A Durazo-Arvizu; Pierre Lukas; Étienne Cavalier; Christian Popp; Christian Beckert; Jan Schultess; Glen Van Slooten; Carole Tourneur; Camille Pease; Ravi Kaul; Alfredo Villarreal; Fiona Ivison; Ralf Fischer; Jody M W van den Ouweland; Chung S Ho; Emmett W K Law; Jean-Nicolas Simard; Renaud Gonthier; Brett Holmquist; Marcelo Cidade Batista; Heather Pham; Alex Bennett; Sarah Meadows; Lorna Cox; Eugene Jansen; Dilshad Ahmed Khan; Kimberly Robyak; Michael H Creer; Mark Kilbane; Patrick J Twomey; James Freeman; Neil Parker; Jinyun Yuan; Robert Fitzgerald; Sohail Mushtaq; Michael W Clarke; Norma Breen; Christine Simpson; Christopher T Sempos
Journal:  Anal Bioanal Chem       Date:  2021-06-28       Impact factor: 4.478

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.